Essential function for the kinase TAK1 in innate and adaptive immune responses

Nature Immunology

Volumn 6, Issue 11, 2005, Pages 1087-1095

  Sato, Shintaro ^a   Sanjo, Hideki ^b,c   Takeda, Kiyoshi ^d   Ninomiya Tsuji, Jun ^e   Yamamoto, Masahiro ^b   Kawai, Taro ^a   Matsumoto, Kunihiro ^f   Takeuchi, Osamu ^a,b   Akira, Shizuo ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE PHASE; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; EMBRYO; FIBROBLASTS; GENE DELETION; IMMUNITY, NATURAL; INTERLEUKIN-17; LYMPHOPOIESIS; MAP KINASE KINASE KINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27544434183     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1255     Document Type: Article

References (47)

1. Aggarwal, B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3, 745-756 (2003).
2. Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147 (1996).
3. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
4. Baud, V. & Karin, M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377 (2001).
5. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
6. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
7. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
8. Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256 (1999).
9. Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011 (1995).
10. Vidal, S. et al. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses. Genes Dev. 15, 1900-1912 (2001).
11. Takaesu, G. et al. TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 326, 105-115 (2003).
12. Irie, T,, Muta, T. & Takeshige, K. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 467, 160-164 (2000).
13. Wan, J. et al. Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1. Mol. Cell. Biol. 24, 192-199 (2004).
14. Shibuya, H. et al. TAB1: An activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272, 1179-1182 (1996).
15. Takaesu, G. et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5, 649-658 (2000).
16. Ishitani, T. et al. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22, 6277-6288 (2003).
17. Cheung, P.C., Nebreda, A.R. & Cohen, P. TAB3, a new binding partner of the protein kinase TAK1. Biochem. J. 378, 27-34 (2004).
18. Sanjo, H. et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol. Cell. Biol. 23, 1231-1238 (2003).
19. Komatsu, Y. et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119, 239-249 (2002).
20. Wagner, M. et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J. Immunol. 172, 954-963 (2004).
21. Kurosaki, T. Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. Immunol. 2, 354-363 (2002).
22. Thome, M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4, 348-359 (2004).
23. Sun, L., Deng, L., Ea, C.K., Xia, Z.P. & Chen, Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301 (2004).
24. Sidorova, E.V., Li-Sheng, L., Devlin, B., Chernishova, I. & Gavrilova, M. Role of different B-cell subsets in the specific and polyclonal immune response to T-independent antigens type 2. Immunol. Lett. 88, 37-42 (2003).
25. Jin, G. et al. Identification of a human NF-κB-activating protein, TAB3. Proc. Natl. Acad. Sci. USA 101, 2028-2033 (2004).
26. Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
27. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
28. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
29. Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 427, 167-171 (2004).
30. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001).
31. Egawa, T. et al. Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation. Curr. Biol. 13, 1252-1258 (2003).
32. Hara, H. et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18, 763-775 (2003).
33. Newton, K. & Dixit, V.M. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13, 1247-1251 (2003).
34. Ruefli-Brasse, A.A., French, D.M. & Dixit, V.M. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581-1584 (2003).
35. Ruland, J., Duncan, G.S., Wakeham, A. & Mak, T.W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749-758 (2003).
36. Xue, L. et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4, 857-865 (2003).
37. Munoz-Sanjuan, I., Bell, E., Altmann, C.R., Vonica, A. & Brivanlou, A.H. Gene profiling during neural induction in Xenopus laevis: Regulation of BMP signaling by posttranscriptional mechanisms and TAB3, a novel TAK1-binding protein. Development 129, 5529-5540 (2002).
38. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995).
39. Tanaka, M. et al. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10, 421-429 (1999).
40. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F. & Verma, I.M. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284, 321-325 (1999).
41. Rudolph, D. et al. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14, 854-862 (2000).
42. Ohkawara, B. et al. Role of the TAK1-NLK-STAT3 pathway in TGF-β-mediated mesoderm induction. Genes Dev. 18, 381-386 (2004).
43. Sakai, K., Mitani, K. & Miyazaki, J. Efficient regulation of gene expression by adenovirus vector-mediated delivery of the CRE recombinase. Biochem. Biophys. Res. Commun. 217, 393-401 (1995).
44. Todaro, G.J. & Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313 (1963).
45. Rickert, R.C., Roes, J. & Rajewsky, K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318 (1997).
46. Sato, S. et al. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14, 783-791 (2002).
47. Sato, S. et al. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165, 7096-7101 (2000).